Seattle Genetics' Series B Round

Seattle Genetics raised a round of funding on April 13, 2000.

Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics develops antibody-drug…

Articles about Seattle Genetics' Series B Round: